logo
  

Moderna To Supply 20 Mln Doses Of Its COVID-19 Vaccine To Peru

Moderna Inc. (MRNA) announced a supply agreement with the government of Peru for 20 million doses of its COVID-19 vaccine to begin delivery in the first quarter of 2022.

The COVID-19 Vaccine Moderna is not currently approved for use in Peru, and the company will work with regulators to pursue necessary approvals prior to distribution.

The company said it is committed to making its vaccine available around the world as it seeks to address the pandemic with its COVID-19 vaccine.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Sandoz, Inc., an unit of Novartis AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high temperatures that may have impacted product effectiveness, the U.S. Food and Drug Administration or FDA said in a statement. Livia Global, Inc., a health and wellness company, is recalling two lots of its Liviaone liquid probiotics citing the possibility of contamination by Pseudomonas aeruginosa, the U.S. Food and Drug Administration said. Pseudomonas aeruginosa is a microorganism found in the environment that, if ingested, can cause life-threatening infection in immunocompromised individuals. United Airlines operated Thursday the first ever passenger flight using 100% Sustainable Aviation Fuel or SAF as part of its efforts to combat climate change. The airline flew the green flight from Chicago's O'Hare International Airport or ORD to Washington, D.C.'s Reagan National Airport or DCA with more than 100 passengers.
Follow RTT